7,8-Dimethoxy-3-(3-iodopropyl)-1,3-dihydro-2H-3-benzazepin-2-one
≥95%
- Product Code: 120784
CAS:
148870-57-9
| Molecular Weight: | 387.21 g./mol | Molecular Formula: | C₁₅H₁₈INO₃ |
|---|---|---|---|
| EC Number: | MDL Number: | MFCD09955403 | |
| Melting Point: | Boiling Point: | 504.5°C at 760 mmHg | |
| Density: | Storage Condition: | 2-8°C, protected from light, stored in an inert gas |
Product Description:
This compound is primarily utilized in research and development within the field of neuroscience and pharmacology. It serves as a selective antagonist for certain dopamine receptor subtypes, making it valuable for studying the role of dopamine in the brain. Its application extends to investigating neurological disorders such as Parkinson's disease, schizophrenia, and other dopamine-related conditions. Additionally, it is used in the synthesis of radiolabeled compounds for imaging studies, aiding in the visualization and understanding of receptor distribution and function in the brain. Its unique structure allows it to interact specifically with targeted receptors, providing insights into therapeutic drug design and the development of treatments for psychiatric and neurological diseases.
Product Specification:
| Test | Specification |
|---|---|
| Appearance | Light Yellow To Yellow Powder Or Crystals |
| Purity (%) | 94.5-100 |
| Infrared Spectrum | Conforms To Structure |
| NMR | Conforms To Structure |
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.250 | 10-20 days | €10.29 |
+
-
|
| 1.000 | 10-20 days | €17.68 |
+
-
|
| 5.000 | 10-20 days | €42.74 |
+
-
|
| 10.000 | 10-20 days | €81.78 |
+
-
|
7,8-Dimethoxy-3-(3-iodopropyl)-1,3-dihydro-2H-3-benzazepin-2-one
This compound is primarily utilized in research and development within the field of neuroscience and pharmacology. It serves as a selective antagonist for certain dopamine receptor subtypes, making it valuable for studying the role of dopamine in the brain. Its application extends to investigating neurological disorders such as Parkinson's disease, schizophrenia, and other dopamine-related conditions. Additionally, it is used in the synthesis of radiolabeled compounds for imaging studies, aiding in the visualization and understanding of receptor distribution and function in the brain. Its unique structure allows it to interact specifically with targeted receptors, providing insights into therapeutic drug design and the development of treatments for psychiatric and neurological diseases.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
€0.00
€0.00
Total :